FDA Clearance Tracker · K121445
TETRACHROME REAGENTS AND TETRACXP SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 26, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jul 26, 2013
Substantially Equivalent
Time to decision
437 days
Received May 15, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K121445
- Device name
- TETRACHROME REAGENTS AND TETRACXP SYSTEM
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Miami, FL
- Received
- May 15, 2012
- Decided
- Jul 26, 2013
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 864.5220
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OYE (Flow Cytometric Reagents And Accessories.).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K121445
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access BNP II510(k)
K262597 · Decided Oct 20, 2026 · 85 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
- Access MeMed BV510(k)
K261109 · Decided Oct 19, 2026 · 199 days after receipt
Device type: Immunoassay For Host Biomarkers Of Infection (QPS) · Laboratory Medicine & Pathology
- Access NT-proBNP510(k)
K262109 · Decided Sep 21, 2026 · 90 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.